Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

keyword rare-diseases

What HCPs think about medical tweetorials

pharmaphorum

OCTOBER 21, 2021

Specialists in disease areas are sometimes seen sharing tweetorials discussing studies of new treatments. Infectious disease doctor Abraar Karan posted a 13-post tweetorial in mid-March 2020, commenting on a Lancet article that examined early learnings from Wuhan. This kind of thread often engages fellow specialists or even patients.

Doctors

Doctors Doctor Trials Research

Grand Rounds January 19, 2024: Why Are Imaging RCTs Different? Lessons From Chest Pain Evaluation Trials (Pamela S. Douglas, MD, MACC, FASE, FAHA)

Rethinking Clinical Trials

JANUARY 23, 2024

People with angina-like symptoms are often not patients with a disease. Most do not have obstructive coronary artery disease (CAD), but a few are very high risk. Costs are rarely a significant factor in comparing different testing approaches. They are trying to follow the guidelines for symptoms and disease.

Trials

Trials Cardiology Clinical Trials Clinical Trials

What HCPs think about medical tweetorials

Grand Rounds January 19, 2024: Why Are Imaging RCTs Different? Lessons From Chest Pain Evaluation Trials (Pamela S. Douglas, MD, MACC, FASE, FAHA)

Stay Connected